(Q43867297)

27 November 2017

Reversal of delta 9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine (English)

1 reference

27 November 2017

Claire M Williams

1

1 reference

PubMed ID

11812541

27 November 2017

Tim C Kirkham

series ordinal

2

1 reference

PubMed ID

11812541

27 November 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

Pharmacology, Biochemistry and Behavior

27 November 2017

1 reference

27 November 2017

71

1 reference

27 November 2017

333-340

1 reference

27 November 2017

1-2

1 reference

Cannabis: Effects on hunger and thirst

27 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900694-3

7 January 2021

Neurobiology of marijuana abuse.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900694-3

7 January 2021

The effects of cannabinoids on the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900694-3

7 January 2021

Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900694-3

7 January 2021

Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900694-3

7 January 2021

The functional neuroanatomy of brain cannabinoid receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900694-3

7 January 2021

Kinetic studies of food intake and sucrose solution preference by rats treated with low doses of delta9-tetrahydrocannabinol

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900694-3

7 January 2021

Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900694-3

7 January 2021

Anti-obesity drugs: a critical review of current therapies and future opportunities

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900694-3

7 January 2021

Appetite suppression and weight loss after the cannabinoid antagonist SR 141716.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900694-3

7 January 2021

delta 9-Tetrahydrocannabinol increases proopiomelanocortin gene expression in the arcuate nucleus of the rat hypothalamus

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900694-3

7 January 2021

Perinatal delta9-tetrahydrocannabinol exposure reduces proenkephalin gene expression in the caudate-putamen of adult female rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900694-3

7 January 2021

Repeated administration of delta9-tetrahydrocannabinol produces a differential time related responsiveness on proenkephalin, proopiomelanocortin and corticotropin releasing factor gene expression in the hypothalamus and pituitary gland of the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900694-3

7 January 2021

SR141716, a CB1 receptor antagonist, decreases the sensitivity to the reinforcing effects of electrical brain stimulation in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900694-3

7 January 2021

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900694-3

7 January 2021

Leptin-regulated endocannabinoids are involved in maintaining food intake

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900694-3

7 January 2021

Multiple serotonin receptors: opportunities for new treatments for obesity?

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900694-3

7 January 2021

Naloxone, an opiate blocker, reduces the consumption of sweet high-fat foods in obese and lean female binge eaters

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900694-3

7 January 2021

Effects of smoked marijuana on food intake and body weight of humans living in a residential laboratory.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900694-3

7 January 2021

delta9-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900694-3

7 January 2021

Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900694-3

7 January 2021

Cannabinoid transmission and reward-related events.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900694-3

7 January 2021

Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900694-3

7 January 2021

Role of 5-HT receptors in the effect of d-fenfluramine on feeding patterns in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900694-3

7 January 2021

2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900694-3

7 January 2021

Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900694-3

7 January 2021

Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900694-3

7 January 2021

Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900694-3

7 January 2021

Anandamide, an endogenous cannabinoid receptor ligand, also interacts with 5-hydroxytryptamine (5-HT) receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900694-3

7 January 2021

Synergistic efects of opioid and cannabinoid antagonists on food intake

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900694-3

7 January 2021

Delta(9)-THC stimulates food intake in Lewis rats: effects on chow, high-fat and sweet high-fat diets

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900694-3

7 January 2021

Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900694-3

7 January 2021

Chronic administration of cannabinoids regulates proenkephalin mRNA levels in selected regions of the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900694-3

7 January 2021

Pharmacological and biochemical interactions between opioids and cannabinoids.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900694-3

7 January 2021

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900694-3

7 January 2021

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900694-3

7 January 2021

Molecular characterization of a peripheral receptor for cannabinoids

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900694-3

7 January 2021

Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid CB1 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900694-3

7 January 2021

Functional interaction between opioid and cannabinoid receptors in drug self-administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900694-3

7 January 2021

Recent clinical experience with dronabinol

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900694-3

7 January 2021

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900694-3

7 January 2021

The dopamine hypothesis of reward: past and current status

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900694-3

7 January 2021

Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900694-3

7 January 2021

Facilitory effect of Δ9-tetrahydrocannabinol on hypothalamically induced feeding

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900694-3

7 January 2021

Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900694-3

7 January 2021

Hyperphagia in pre-fed rats following oral delta9-THC.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900694-3

7 January 2021

10.1016/S0091-3057(01)00694-3

Identifiers

DOI

1 reference

27 November 2017

1 reference

PubMed ID

11812541